Chemical Control of Powdery Mildew of Bigleaf Hydrangea

The efficacy of the fungicide pydiflumetofen + difenoconazole (Postiva) was evaluated at varying application rates and intervals for the control of powdery mildew (Golovinomyces orontii, formerly Erysiphe polygoni) in bigleaf hydrangea (Hydrangea macrophylla ‘Nikko Blue’). Container-grown hydrangeas were arranged in a completely randomized design with six single-plant replications. Experiments were done in 2022 and 2023 under both greenhouse and shade house conditions (56% shade). Powdery mildew in hydrangea was developed naturally. Pydiflumetofen + difenoconazole at 1.1, 1.6, and 2.2 ml·L−1 and a standard fungicide azoxystrobin + benzovindiflupyr (Mural) at 0.5 g·L−1 were sprayed to runoff on 2-, 4-, and 6-week intervals. Plants that were not treated with fungicide served as the control. Plants were evaluated weekly for disease severity (0% to 100% foliage affected) and defoliation (0% to 100% defoliation). The season-long area under the disease progress curve (AUDPC) and defoliation progress curve (AUDFC) were calculated for the evaluation period. The initial and final plant height and width were recorded, and height and width increase were determined. Pydiflumetofen + difenoconazole and azoxystrobin + benzovindiflupyr significantly reduced final disease severity, AUDPC, and defoliation both in the greenhouse and shade house compared with control plants. In both greenhouse trials and the 2022 shade house trial, AUDFC was reduced in all treatments compared with the control plants. However, AUDFC was not reduced by all treatments in the 2023 shade house trial. Pooled over application intervals, the low rate of pydiflumetofen + difenoconazole was as effective as the medium and high rates of pydiflumetofen + difenoconazole and azoxystrobin + benzovindiflupyr in reducing final powdery mildew severity and AUDPC both in the greenhouse and shade house in both 2022 and 2023. No significant differences between application intervals were noted in final disease severity and progress. Control of powdery mildew with fungicides failed to increase plant dimensions (i.e., plant height and width) compared with the no fungicide control. Because all application rates and intervals of pydiflumetofen + difenoconazole provided comparable powdery mildew disease control, it is suggested that using a low rate of pydiflumetofen + difenoconazole with the longest application interval (6 weeks) is the most cost-effective approach for managing powdery mildew in bigleaf hydrangeas.